down arrow

Bharat Immunolog

3
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE994B01014
  • NSEID:
  • BSEID: 524663
INR
22.49
0.42 (1.9%)
BSENSE

Apr 11, 12:51 PM

BSE+NSE Vol: 8.38 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Standalone - Profit And Loss Results
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2023 is -43.09% vs -8.14% in Mar 2022

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2023 is -270.44% vs 76.12% in Mar 2022

stock-summary

Interest

YoY Growth in year ended Mar 2023 is 25.92% vs 17.04% in Mar 2022

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2023 is -94.85% vs 51.67% in Mar 2022

Compare Profit and Loss Results of Bharat Immunolog
Markets Mojo
Figures in Rs cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
44.00
9,264.00
-9,220.00
-99.53%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
44.00
9,264.00
-9,220.00
-99.53%
Expenditure (Ex Depriciation)
Stock Adjustments
5.00
-25.00
30.00
120.00%
Raw Materials Consumed
33.00
2,933.00
-2,900.00
-98.87%
Power & Fuel Cost
1.00
70.00
-69.00
-98.57%
Employee Cost
15.00
1,982.00
-1,967.00
-99.24%
Operating Expenses
3.00
143.00
-140.00
-97.90%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
806.00
-806.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
136.00
-134.00
-98.53%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
63.00
6,939.00
-6,876.00
-99.09%
Operating Profit (PBDIT) excl Other Income
-18.00
2,325.00
-2,343.00
-100.77%
Other Income
2.00
266.00
-264.00
-99.25%
Operating Profit (PBDIT)
-15.00
2,592.00
-2,607.00
-100.58%
Interest
7.00
15.00
-8.00
-53.33%
Profit before Depriciation and Tax
-22.00
2,577.00
-2,599.00
-100.85%
Depreciation
0.00
317.00
-317.00
-100.00%
Profit Before Taxation & Exceptional Items
-22.00
2,259.00
-2,281.00
-100.97%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-22.00
2,259.00
-2,281.00
-100.97%
Provision for Tax
-5.00
436.00
-441.00
-101.15%
Profit After Tax
-17.00
1,823.00
-1,840.00
-100.93%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-49.00
7,868.00
-7,917.00
-100.62%
Profit Available for appropriations
-66.00
9,691.00
-9,757.00
-100.68%
Appropriations
-66.00
9,691.00
-9,757.00
-100.68%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-3.95
45.52
-49.47
-108.68%
Profit And Loss - Net Sales
Net Sales 44.61 Cr
in Mar 2023

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2023 is -43.09% vs -8.14% in Mar 2022

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -18.47 Cr
in Mar 2023

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2023 is -270.44% vs 76.12% in Mar 2022

Profit And Loss - Interest
Interest 7.04 Cr
in Mar 2023

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2023 is 25.92% vs 17.04% in Mar 2022

Profit And Loss - Profit After Tax
Profit After Tax -17.06 Cr
in Mar 2023

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2023 is -94.85% vs 51.67% in Mar 2022